Skip to content

Keros Therapeutics, Inc.: filings

Every Keros Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 26 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-03fiscal Q2 2026411230001664710-26-000049
10-Q2026-05-14fiscal Q1 202640850001664710-26-000030
10-K2026-03-04fiscal FY 2025501010001664710-26-000018
10-Q2025-11-05fiscal Q3 2025421290001664710-25-000089
10-Q2025-08-06fiscal Q2 2025421250001664710-25-000070
10-Q2025-05-06fiscal Q1 202542890001664710-25-000046
10-K2025-02-26fiscal FY 2024471240001664710-25-000018
10-Q2024-11-06fiscal Q3 2024401180001664710-24-000091
10-Q2024-08-07fiscal Q2 2024381110001664710-24-000068
10-Q2024-05-08fiscal Q1 202439830001664710-24-000039
10-K2024-02-28fiscal FY 2023471260001664710-24-000017
10-Q2023-11-06fiscal Q3 2023401180001664710-23-000066
10-Q2023-08-07fiscal Q2 2023391100001664710-23-000050
10-Q2023-05-04fiscal Q1 202339820001664710-23-000030
10-K2023-03-03fiscal FY 202247970001664710-23-000021
10-Q2022-11-03fiscal Q3 2022411250001664710-22-000056
10-Q2022-08-04fiscal Q2 2022411210001664710-22-000040
10-Q2022-05-05fiscal Q1 202139830001664710-22-000019
10-K2022-03-09fiscal FY 202148970001664710-22-000011
10-Q2021-11-04fiscal Q3 2021401220001664710-21-000065
10-Q2021-08-05fiscal Q2 2021401180001664710-21-000053
10-Q2021-05-06fiscal Q1 202133710001664710-21-000025
10-K2021-03-25fiscal FY 202043870001664710-21-000018
10-Q2020-11-10fiscal Q3 2020341030001664710-20-000050
10-Q2020-08-13fiscal Q2 202034990001664710-20-000027
10-Q2020-05-22fiscal Q1 202034730001664710-20-000006

Inspect the source

Entity
Keros Therapeutics, Inc. / CIK 0001664710
Captured
2026-09-21T17:22:31.454Z
SEC response SHA-256
47240cffe62384e0ef9381e3b6b5a32a684071602d0ea9728d8fcaa516b8dfae

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001664710.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))